Novoron Recognized as Innovative San Diego Biotech

SAN DIEGO, May 4, 2016 – Two local magazines have recognized Novoron as an innovative company in San Diego’s hot biotech hub.

Our City San Diego named Novoron in the magazine’s list of 25 leading life science companies that could positively impact the San Diego economy in the coming years.  This article featured notable biotech companies including Illumina and Dexcom, with over 30 years combined experience creating innovative and life changing products, as well as Human Longevity, Inc., led by Dr. Craig Venter.

“To be included with these prestigious companies is very exciting for us. Recognition like this is a reflection of all the hard work by the Novoron team and our supportive collaborators," said Novoron CEO and President, Dr. Travis Stiles.

Hatch, San Diego Magazine’s new innovation and tech-focused magazine, highlighted Novoron’s research on RhoA protein and how it could support neuronal regeneration in spinal cord injury and multiple sclerosis.  The article featured 25 Very Important Proteins (VIPs) that are being investigated in the San Diego area to help understand human disease and develop novel treatments.

Novoron Bioscience is a startup biotech working to develop the first ever neuroregenerative therapies for conditions such as spinal cord injury and multiple sclerosis. Their novel technology also garnered attention earlier this year when Novoron was recognized by Xconomy as one of the 12 San Diego life science companies to watch in 2016.